{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:39:02Z","timestamp":1790919542327,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":101,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642077999","type":"print"},{"value":"9783662057674","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-662-05767-4_3","type":"book-chapter","created":{"date-parts":[[2013,1,14]],"date-time":"2013-01-14T11:59:59Z","timestamp":1358164799000},"page":"33-60","source":"Crossref","is-referenced-by-count":14,"title":["Anthrax Vaccines"],"prefix":"10.1007","author":[{"given":"A. M.","family":"Friedlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"Welkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. E.","family":"Ivins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.75.2.129","volume":"75","author":"S Auerbach","year":"1955","unstructured":"Auerbach S, Wright GG (1955) Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis. J Immunol 75: 129\u2013133","journal-title":"J Immunol"},{"key":"3_CR2","first-page":"270","volume":"37","author":"O Bail","year":"1904","unstructured":"Bail O (1904) Untersuchungen uber naturliche und kuntliche Milzbrandimmunitat. Centralbl f Bakt 37: 270\u2013280","journal-title":"Centralbl f Bakt"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1128\/IAI.67.2.562-567.1999","volume":"67","author":"JP Barnard","year":"1999","unstructured":"Barnard JP, Friedlander AM (1999) Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen. Infect Immun 67: 562\u2013567","journal-title":"Infect Immun"},{"key":"3_CR4","first-page":"144","volume":"35","author":"FC Belton","year":"1954","unstructured":"Belton FC, Strange RE (1954) Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br J Exp Pathol 35: 144\u2013152","journal-title":"Br J Exp Pathol"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1021\/bi972657b","volume":"37","author":"EL Benson","year":"1998","unstructured":"Benson EL, Huynh PD, Finkelstein A, Collier RJ (1998) Identification of residues lining the anthrax protective antigen channel. Biochemistry 37: 3941\u20133948","journal-title":"Biochemistry"},{"key":"3_CR6","first-page":"85","volume":"61","author":"R Berendt","year":"1985","unstructured":"Berendt R, Jemski J, Johnson-Winegar A, Ivins B (1985) The use of toxin components for the immunoprophylaxis of inhalation anthrax. Abstr Ann Meeting Am Soc Microbiol E61: 85","journal-title":"Abstr Ann Meeting Am Soc Microbiol"},{"key":"3_CR7","first-page":"629","volume-title":"Plotkin SA","author":"P Brachman","year":"1999","unstructured":"Brachman P, Friedlander AM (1999) Anthrax. In: Plotkin SA, Orenstein WA (eds) Vaccines. W. B. Saunders Philadelphia p. 629\u2013637"},{"key":"3_CR8","first-page":"632","volume":"52","author":"PS Brachman","year":"1962","unstructured":"Brachman PS, Gold H, Plotkin SA, Fekety FR, Werrin M, Ingraham NR (1962) Field evaluation of a human anthrax vaccine.Am J Public Health 52: 632\u2013645","journal-title":"Field evaluation of a human anthrax vaccine.Am J Public Health"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2672.1999.00895.x","volume":"87","author":"F Brossier","year":"1999","unstructured":"Brossier F, Mock M, Sirard J-C (1999) Antigen delivery by attenuated Bacillus anthracis: new prospects in veterinary vaccines. J Appl Microbiol 87: 298\u2013302","journal-title":"J Appl Microbiol"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","volume":"68","author":"F Brossier","year":"2000","unstructured":"Brossier F, Weber-Levy M, Mock M, Sirard J-C (2000) Role of toxin functional domains in anthrax pathogenesis. Infect Immun 68: 1781\u20131786","journal-title":"Infect Immun"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/IAI.67.2.964-967.1999","volume":"67","author":"F Brossier","year":"1999","unstructured":"Brossier F, Sirard JC, Guidi-Rontani C, Duflot E, Mock M (1999) Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect Immun 67: 964\u2013967","journal-title":"Infect Immun"},{"key":"3_CR12","unstructured":"Broster MG, Hibbs SE (1990) Protective efficacy of anthrax vaccines against aerosol challenge. Proceedings of the International Workshop on Anthrax, 11\u201313 April 1989, Winchester, UK Salisbury Med Bull Special suppl No. 68, pp 91\u201392"},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2958.1990.tb00685.x","volume":"4","author":"A Cataldi","year":"1990","unstructured":"Cataldi A, Labruyere E, Mock M (1990) Construction and characterization of a pro- tective antigen-deficient Bacillus anthracis strain. Mol Microbiol 4: 1111\u20131117","journal-title":"Mol Microbiol"},{"key":"3_CR14","first-page":"35","volume":"82","author":"S Chatfield","year":"1994","unstructured":"Chatfield S, Roberts M, Li J, Starns A, Dougan G (1994) The use of live attenuated Salmonella for oral vaccination. Dev Biol Stand 82: 35\u201342","journal-title":"Dev Biol Stand"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","volume":"68","author":"S Cohen","year":"2000","unstructured":"Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A (2000) Attenuated nontoxigenic and nonencapsulated Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 68:4549\u2013 4558","journal-title":"Infect Immun"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0264-410X(94)90148-1","volume":"12","author":"NM Coulson","year":"1994","unstructured":"Coulson NM, Fulop M, Titball RM (1994) Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL3261, affords protection against anthrax spore challenge. Vaccine 12: 1395\u20131401","journal-title":"Vaccine"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/infdis\/80.1.14","volume":"80","author":"WJ Cromartie","year":"1947","unstructured":"Cromartie WJ, Watson DW, Bloom WL, Heckly RJ (1947) Studies on infection with Bacillus anthracis. II. The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infection. J Infect Dis 80: 14\u201327","journal-title":"J Infect Dis"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1128\/IAI.56.2.349-356.1988","volume":"56","author":"JW Ezzell","year":"1988","unstructured":"Ezzell JW Jr,Abshire TG (1988) Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect Immun 56: 349\u2013356","journal-title":"Infect Immun"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1099\/00221287-138-3-543","volume":"138","author":"JW Ezzell Jr","year":"1992","unstructured":"Ezzell JW Jr, Abshire TG (1992) Serum protease cleavage of Bacillus anthracis protective antigen. J Gen Microbiol 138: 543\u2013549","journal-title":"J Gen Microbiol"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AEM.64.3.982-991.1998","volume":"64","author":"JW Farchaus","year":"1998","unstructured":"Farchaus JW, Ribot WJ, Jendrek S, Little SF (1998) Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis. Appl Environ Microbiol 64: 982\u2013991","journal-title":"Appl Environ Microbiol"},{"key":"3_CR21","unstructured":"Fellows PF, Linscott MK, Iv ins BE, Pitt MLM, Rossi CA, Gibbs PH, Friedlander AM (200 1) Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine (in press)"},{"key":"3_CR22","volume-title":"Abstr Ann Meeting Am Soc Microbiol, Los Angeles CA P","author":"PF Fellows","year":"2000","unstructured":"Fellows PF, Linscott MK, Little SF, Gibbs P, Iv ins BE (2000) Anthrax vaccine efficacy in the syrian golden hamster. Abstr Ann Meeting Am Soc Microbiol, Los Angeles CA P. 299 E-28"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","volume":"282","author":"AM Friedlander","year":"1999","unstructured":"Friedlander AM, Pittman PR, Parker GW (1999) Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282: 2104\u20132106","journal-title":"JAMA"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/JB.91.3.930-933.1966","volume":"91","author":"ES Fubra","year":"1966","unstructured":"Fubra ES (1966) Nonproteolytic, avirulent Bacillus anthracis as a live vaccine. J Bacteriol 91: 930\u2013933","journal-title":"J Bacteriol"},{"key":"3_CR25","first-page":"47","volume":"8185","author":"NE Gefen","year":"1970","unstructured":"Gefen NE, Shustikov VM, Rudneva, OA, Fedyaev SF, Tsimlyansky GT, Golubitsky EA, Lazareva ES (1970) A study of reactogenicity, harmlessness and immunological efficacy of aerosol method of immunization against anthrax in trial on man. Zh Mikrobiol Epidemiol Immunobiol 47: 81\u201385 (In Russian)","journal-title":"Zh Mikrobiol Epidemiol Immunobiol"},{"key":"3_CR26","first-page":"394","volume":"27","author":"GP Gladstone","year":"1946","unstructured":"Gladstone GP (1946) Immunity to anthrax: protective antigen present in cell-free culture filtrates. Br J Exp Pathol 27: 394\u2013418","journal-title":"Br J Exp Pathol"},{"key":"3_CR27","first-page":"427","volume-title":"The genus Bacillus. U","author":"RE Gordon","year":"1973","unstructured":"Gordon RE, Haynes WD, Hor-Nay Pang C (1973) The genus Bacillus. U. S. Dep Agric Agric Handb No. 427"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","volume":"17","author":"M-L Gu","year":"1999","unstructured":"Gu M-L, Leppla SH, Klinman DM (1999) Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. Vaccine 17:340\u2013 344","journal-title":"Vaccine"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/prep.1999.1066","volume":"16","author":"P Gupta","year":"1999","unstructured":"Gupta P, Waheed SM, Bhatnagar R (1999) Expression and purification of the recombinant protective antigen of Bacillus anthracis. Protein Expr Purif 16:369\u2013 376","journal-title":"Protein Expr Purif"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/0264-410X(95)00011-O","volume":"13","author":"RK Gupta","year":"1995","unstructured":"Gupta RK, Siber GR (1995) Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13: 1263\u20131276","journal-title":"Vaccine"},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","volume":"2","author":"P Hambleton","year":"1984","unstructured":"Hambleton P, Carman JA, Turnbull PCB (1984) Anthrax: the disease in relation to vaccines. Vaccine 2: 125\u2013132","journal-title":"Vaccine"},{"key":"3_CR32","unstructured":"Hambleton P, Turnbull PCB (1990) Anthrax vaccine development: a continuing story. In: Mizrahi, A (ed) Bacterial Vaccines. Liss, New York, pp 105\u2013122"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(00)61181-9","volume":"1","author":"AE Hodgson","year":"1941","unstructured":"Hodgson AE (1941) Cutaneous anthrax. Lancet 1: 811\u2013813","journal-title":"Lancet"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/IAI.59.6.1961-1965.1991","volume":"59","author":"LC Iacono-Connors","year":"1991","unstructured":"Iacono-Connors LC, Welkos SL, Ivins BE, Dalrymple JM (1991) Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals. Infect Immun 59: 1961\u20131965","journal-title":"Infect Immun"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/IAI.52.2.454-458.1986","volume":"52","author":"BE Ivins","year":"1986","unstructured":"Ivins BE, Ezzell Jr, JW, Jemski J, Hedlund, KW, Ristroph JD, Leppla SH (1986) Immunization studies with attenuated strains of Bacillus anthracis. Infect Immun 52: 454\u2013458","journal-title":"Infect Immun"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","volume":"12","author":"BE Ivins","year":"1994","unstructured":"Ivins BE, Fellows PF, Nelson GO (1994) Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine 12:872\u2013 874","journal-title":"Vaccine"},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","volume":"13","author":"BE Ivins","year":"1995","unstructured":"Ivins BE, Fellows P, Pitt L, Estep J, Farchaus J, Friedlander A, Gibbs P (1995) Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 13: 1779\u20131784","journal-title":"Vaccine"},{"key":"3_CR38","first-page":"125","volume":"87","author":"BE Ivins","year":"1996","unstructured":"Ivins BE, Fellows PF, Pitt MLM, Estep JE, Welkos SL, Worsham PL, Friedlander AM (1996) Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med Bull 87: 125\u2013126","journal-title":"Salisbury Med Bull"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","volume":"16","author":"BE Ivins","year":"1998","unstructured":"Ivins BE, Pitt MLM, Fellows PF, Farchaus JW, Benner GE, Waag DM, Little SF, Anderson JR, Gibbs PH, Friedlander AM (1998) Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine 16: 1141\u20131148","journal-title":"Vaccine"},{"key":"3_CR40","first-page":"537","volume":"54","author":"BE Ivins","year":"1986","unstructured":"Ivins BE, Welkos SL (1986) Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis. J Bacteriol 54: 537\u2013542","journal-title":"J Bacteriol"},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/BF00152686","volume":"4","author":"BE Ivins","year":"1988","unstructured":"Ivins BE, Welkos SL (1988) Recent advances in the development of an improved, human anthrax vaccine. Eur J Epidemiol 4: 12\u201319","journal-title":"Eur J Epidemiol"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","volume":"58","author":"BE Ivins","year":"1990","unstructured":"Ivins BE, Welkos SL, Knudson GB, Little SF (1990) Immunization against anthrax with aromatic compound-dependent (Aro\u2013) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun 58: 303\u2013308","journal-title":"Infect Immun"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","volume":"60","author":"BE Ivins","year":"1992","unstructured":"Ivins BE, Welkos SL, Little SF, Crumrine MH, Nelson GO (1992) Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect Immun 60: 662\u2013668","journal-title":"Infect Immun"},{"key":"3_CR44","unstructured":"Ivins BE, Welkos SL, Little SF, Knudson GB (1990) Cloned protective activity and progress in development of improved anthrax vaccines. Proceedings of the International Workshop on Anthrax, 11\u201313 April 1989, Winchester, UK Salisbury Med Bull Special suppl No. 68, pp 86\u201388"},{"key":"3_CR45","first-page":"771","volume":"18","author":"FC Jackson","year":"1957","unstructured":"Jackson FC, Wright GG,Armstrong J (1957) Immunization of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine. Am J Vet Res 18: 771\u2013777","journal-title":"Immunization of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine. Am J Vet Res"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.88.1.15","volume":"88","author":"F Klein","year":"1962","unstructured":"Klein F, DeArmon Jr, IA, Lincoln RE, Mahlandt BG, Fernelius AL (1962) Immunological studies of anthrax. II. Levels of immunity against Bacillus anthracis obtained with protective antigen and live vaccine. J Immunol 88: 15\u201319","journal-title":"J Immunol"},{"key":"3_CR47","first-page":"543","volume-title":"Anthrax Toxins in: Moss J, Iglewksi B","author":"SH Leppla","year":"1996","unstructured":"Leppla SH (1996) Anthrax Toxins in: Moss J, Iglewksi B, Vaughan M, Tu AT (eds) Bacterial toxins and virulence factors in disease. Marcel Dekker Inc P. 543\u2013572"},{"key":"3_CR48","first-page":"361","volume-title":"Microbial Toxins","author":"RE Lincoln","year":"1970","unstructured":"Lincoln RE, Fish DC (1970) Anthrax toxin. In: Montie, TC, Kadis S, Ajl SJ (eds) Microbial Toxins. Academic Press, New York, pp 361\u2013414"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","volume":"2","author":"SF Little","year":"1999","unstructured":"Little SF, Ivins BE (1999) Molecular pathogenesis of Bacillus anthracis infection. Microbes and Infection 2: 131\u2013139","journal-title":"Microbes and Infection"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","volume":"65","author":"SF Little","year":"1997","unstructured":"Little SF, Ivins BE, Fellows PF, Friedlander AM (1997) Passive protection studies against Bacillus anthracis infection in guinea pigs using monoclonal and polyclonal antibodies. Infect Immun 65: 5171\u20135175","journal-title":"Infect Immun"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.52.2.509-512.1986","volume":"52","author":"SF Little","year":"1986","unstructured":"Little SF, Knudson GB (1986) Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Infect Immun 52: 509\u2013512","journal-title":"Infect Immun"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.58.6.1606-1613.1990","volume":"58","author":"SF Little","year":"1990","unstructured":"Little SF, Leppla SH, Friedlander AM(1990) Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infect Immun 58: 1606\u20131613","journal-title":"Infect Immun"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1099\/13500872-142-3-707","volume":"142","author":"SP Little","year":"1996","unstructured":"Little SP, Novak JM, Lowe JR, Leppla SH, Singh Y, Klimpel KR, Lidgerding BC, Friedlander AM (1996) Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 142: 707\u2013715","journal-title":"Microbiology"},{"key":"3_CR54","first-page":"96","volume-title":"Immunologic studies of anthrax. IV","author":"BG Mahlandt","year":"1966","unstructured":"Mahlandt BG, Klein F, Lincoln RE, Haines BW, Jones WI, Friedman RH (1966) Immunologic studies of anthrax. IV. Evaluation of the immunogenicity of three components of anthrax toxin. J Immunol 96: 727\u2013733"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","volume":"16","author":"BW Mcbride","year":"1998","unstructured":"McBride BW, Mogg A, Telfer JL, Lever MS, Miller J, Turnbull PCB, Baillie L (1998) Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. Vaccine 16: 810\u2013817","journal-title":"Vaccine"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/IAI.39.1.371-376.1983","volume":"38","author":"P Mikesell","year":"1983","unstructured":"Mikesell P, Ivins BE, Ristroph JD, Dreier TM (1983) Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun 38: 371\u2013376","journal-title":"Infect Immun"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1472-765X.1998.00274.x","volume":"26","author":"J Miller","year":"1998","unstructured":"Miller J, McBride BW, Manchee RJ, Moore P, Baillie LWJ (1998) Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis. Lett Appl Microbiol 26: 56\u201360","journal-title":"Lett Appl Microbiol"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"17186","DOI":"10.1016\/S0021-9258(18)41911-4","volume":"267","author":"JM Novak","year":"1992","unstructured":"Novak JM, Stein M-P, Little SF, Leppla SH, Friedlander AM (1992) Functional characterization of protease-treated Bacillus anthracis protective antigen. J Biol Chem 267: 17186\u201317193","journal-title":"J Biol Chem"},{"key":"3_CR59","first-page":"64","volume":"710","author":"H-B Oh","year":"1998","unstructured":"Oh H-B, Park Y-M, Seong W-K (1998) Expression of Bacillus anthracis protective antigen in Bacillus brevis. Abstracts of the 3rd International Conference on Anthrax, Plymouth, England, September 7\u201310, 1998. P. 64.","journal-title":"September"},{"key":"3_CR60","first-page":"429","volume":"92","author":"L Pasteur","year":"1881","unstructured":"Pasteur L (1881) De l\u2019attenuation des virus et de leur retour a la virulence. CR Acad Sci Agric Bulg 92: 429\u2013435","journal-title":"CR Acad Sci Agric Bulg"},{"key":"3_CR61","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/385833a0","volume":"385","author":"C Petosa","year":"1997","unstructured":"Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC (1997) Crystal structure of the anthrax toxin protective antigen. Nature 385: 833\u2013838","journal-title":"Nature"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/IAI.59.10.3472-3477.1991","volume":"59","author":"C Pezard","year":"199","unstructured":"Pezard C, Berche P, Mock M (199 1) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59: 3472\u20133477","journal-title":"Infect Immun"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1099\/00221287-139-10-2459","volume":"139","author":"C Pezard","year":"1993","unstructured":"Pezard C, Duflot E, Mock M (1993) Construction of B. anthracis mutant strains producing a single toxin component. J Gen Microbiol 139: 2459\u20132463","journal-title":"J Gen Microbiol"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","volume":"63","author":"C Pezard","year":"1995","unstructured":"Pezard C, Weber-Levy M, Sirard J-C, Berche P, Mock M (1995) Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun 63: 1369\u20131372","journal-title":"Infect Immun"},{"key":"3_CR65","unstructured":"Pitt MLM, Ivins B, Estep J, Farchaus J, Friedlander AM (1996 a) Comparative efficacy of a recombinant protective antigen vaccine against inhalation anthrax in guinea pigs, rabbits, and rhesus monkeys. Abstr Ann Meeting Am Soc Microbiol, Atlanta GA P. 278 E-70"},{"key":"3_CR66","first-page":"130","volume":"87","author":"MLM Pitt","year":"1996","unstructured":"Pitt MLM, Ivins BE, Estep JE, Farchaus J, Friedlander AM (1996b) Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax. Salisbury Med Bull 87: 130","journal-title":"Salisbury Med Bull"},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","volume":"87","author":"MLM Pitt","year":"1999","unstructured":"Pitt MLM, Little SF, Ivins BE, Fellows PF, Boles J, Barth J, Hewetson JH, Friedlander, AM (1999) In vitro correlate of immunity in an animal model of inhalational anthrax. J Appl Microbiol 87: 304","journal-title":"J Appl Microbiol"},{"key":"3_CR68","first-page":"1","volume-title":"Plotkin SA","author":"SL Plotkin","year":"1999","unstructured":"Plotkin SL, Plotkin SA (1999) A short history of vaccination. In: Plotkin SA, Orenstein WA (eds) Vaccines.WB Saunders, Philadelphia pp 1\u201312"},{"key":"3_CR69","unstructured":"Preisz H (1911) Quoted in Anthrax. (1955) In: Wilson GS, Miles AA (eds) Topley and Wilson\u2019s Principles of Bacteriology and Immunity. Williams Wilkins, Baltimore p 1950"},{"key":"3_CR70","first-page":"239","volume-title":"Replicon-helper systems from attenuated Venezuelan Equine Encephalitis Virus","author":"P Pushko","year":"1997","unstructured":"Pushko P, Parker M, Ludwig GV, Davis NL, Johnston RE, Smith JF (1997) Replicon-helper systems from attenuated Venezuelan Equine Encephalitis Virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology 239: 389\u2013401"},{"key":"3_CR71","first-page":"330","volume":"11","author":"M Puziss","year":"1963","unstructured":"Puziss M, Manning LC, Lynch LW, Barclay E,Abelow I, Wright GG (1963) Large-scale production of protective antigen of Bacillus anthracis anaerobic cultures. Appl Microbiol 11: 330\u2013334","journal-title":"Large-scale production of protective antigen of Bacillus anthracis anaerobic cultures. Appl Microbiol"},{"key":"3_CR72","first-page":"85","volume-title":"Studies on immunity in anthrax. X","author":"M Puziss","year":"1962","unstructured":"Puziss M, Wright GG (1962) Studies on immunity in anthrax. X. Gel-adsorbed protective antigen for immunization of man. J Bacteriol 85: 230\u2013236"},{"key":"3_CR73","first-page":"755","volume":"68","author":"CE Salsbery","year":"1926","unstructured":"Salsbery CE (1926) Anthrax aggressin. J Am Vet Med Assn 68: 755\u2013772","journal-title":"J Am Vet Med Assn"},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"8371","DOI":"10.1074\/jbc.M008309200","volume":"276","author":"BR Sellmann","year":"2001","unstructured":"Sellmann BR, Nassi S, Collier RJ (2001) Point mutations in anthrax protective antigen that block translocation. J Biol Chem 276: 8371\u20138376","journal-title":"J Biol Chem"},{"key":"3_CR75","first-page":"245","volume":"84","author":"F Schodel","year":"1995","unstructured":"Schodel F, Curtiss 3rd R (1995) Salmonella as oral vaccine carriers. Dev Biol Stand 84: 245\u2013253","journal-title":"Dev Biol Stand"},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0264-410X(94)90223-2","volume":"12","author":"E Shlyakhov","year":"1994","unstructured":"Shlyakhov E, Rubinstein E (1994) Human live anthrax vaccine in the former USSR. Vaccine 12: 727\u2013730","journal-title":"Vaccine"},{"key":"3_CR77","first-page":"47","volume":"117120","author":"VP Shuylak","year":"1970","unstructured":"Shuylak VP (1970) Epidemiological efficacy of anthrax STI vaccine in Tadjik SSR. Zh Microbiol Epidemiol Immunobiol 47: 117\u2013120 (In Russian)","journal-title":"Zh Microbiol Epidemiol Immunobiol"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1016\/S0021-9258(18)98643-6","volume":"266","author":"Y Singh","year":"1991","unstructured":"Singh Y, Klimpel KR, Quinn CP, Chaudhary VK, Leppla SH(1991) The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity. J Biol Chem 266: 15493\u201315497","journal-title":"J Biol Chem"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","volume":"66","author":"Y Singh","year":"1998","unstructured":"Singh Y, Ivins BE, Leppla SH (1998) Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis. Infect Immun 66: 3447\u20133448","journal-title":"Infect Immun"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/IAI.67.4.1853-1859.1999","volume":"67","author":"Y Singh","year":"1999","unstructured":"Singh Y, Klimpel KR, Goel S, Swain PK, Leppla SH (1999) Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun 67: 1853\u20131859","journal-title":"Infect Immun"},{"key":"3_CR81","first-page":"1554","volume":"26","author":"H Smith","year":"1967","unstructured":"Smith H, Stoner H (1967) Anthrax toxic complex. Fed Proc 26: 1554\u20131557","journal-title":"Fed Proc"},{"key":"3_CR82","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1099\/00221287-31-2-329","volume":"31","author":"JL Stanley","year":"1963","unstructured":"Stanley JL, Smith H (1963) The three factors of anthrax toxin: their immunogenicity and lack of demonstrable enzymatic activity. J Gen Microbiol 31: 329\u2013337","journal-title":"J Gen Microbiol"},{"key":"3_CR83","first-page":"271","volume":"8","author":"M Sterne","year":"1937","unstructured":"Sterne M (1937) Variation in Bacillus anthracis. Onderstepoort J Vet Sci Anim Ind 8: 271","journal-title":"Onderstepoort J Vet Sci Anim Ind"},{"key":"3_CR84","first-page":"53","volume":"13","author":"M Sterne","year":"1942","unstructured":"Sterne M, Nichol J, Lambrechts NS (1942) The effect of large-scale active immunization against anthrax. J S African Vet Med Assoc 13: 53\u201363","journal-title":"J S African Vet Med Assoc"},{"key":"3_CR85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1017\/S0022172400063488","volume":"85","author":"WD Tigertt","year":"1980","unstructured":"Tigertt WD (1980) Anthrax. William Smith Greenfield, MD FRCP. Concerning the priority due to him for the production of the first vaccine against anthrax. J Hyg 85: 415\u2013420","journal-title":"J Hyg"},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","volume":"9","author":"PCB Turnbull","year":"1991","unstructured":"Turnbull PCB (1991) Anthrax vaccines: past, present and future. Vaccine 9: 533\u2013539","journal-title":"Vaccine"},{"key":"3_CR87","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","volume":"13","author":"PCB Turnbull","year":"2000","unstructured":"Turnbull PCB (2000) Current status of immunization against anthrax: old vaccines may be here to stay for a while. Current Opinion in Infectious Diseases 13: 113\u2013120","journal-title":"Current Opinion in Infectious Diseases"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","volume":"52","author":"PC Turnbull","year":"1986","unstructured":"Turnbull PC, Broster, MG, Carman JA, Manchee RJ, Melling J (1986) Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infect Immun 52: 356\u2013359","journal-title":"Infect Immun"},{"key":"3_CR89","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00189414","volume":"177","author":"PCB Turnbull","year":"1988","unstructured":"Turnbull PCB, Leppla SH, Broster MG, Melling J (1988) Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med Microbiol Immunol 177: 293\u2013303","journal-title":"Med Microbiol Immunol"},{"key":"3_CR90","unstructured":"Turnbull PCB, Quinn CP, Hewson R, Stockbridge MC, Melling J (1990) Protection conferred by microbially-supplemented UK and purified PA vaccines. Proceedings of the International Workshop on Anthrax, 11\u201313 April 1989, Winchester, UK Salisbury Med Bull Special suppl No. 68, pp 89\u201391"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","volume":"67","author":"M Varughese","year":"1999","unstructured":"Varughese M, Teixeira AV, Liu S, Leppla SH (1999) Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect Immun 67: 1860\u20131865","journal-title":"Infect Immun"},{"key":"3_CR92","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/0092-8674(83)90402-6","volume":"34","author":"M Vodkin","year":"1983","unstructured":"Vodkin M, Leppla SH (1983) Cloning of the protective antigen gene of Bacillus anthracis. Cell 34: 693\u2013696","journal-title":"Cell"},{"key":"3_CR93","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/80.1.28","volume":"80","author":"DW Watson","year":"1947","unstructured":"Watson DW, Cromartie WJ, Bloom WL, Kegeles G, Heckly RJ (1947) Studies on infection with Bacillus anthracis. III. Chemical and immunological properties of the protective antigen in crude extracts of skin lesions of B. anthracis. J Infect Dis 80: 28\u201352","journal-title":"J Infect Dis"},{"key":"3_CR94","first-page":"49","volume":"68","author":"S Welkos","year":"1990","unstructured":"Welkos S, Becker D, Friedlander A, Trotter R (1990) Pathogenesis and host resistance to Bacillus anthracis: a mouse model. Proceedings of the International Workshop on Anthrax, 11\u2013 13 April 1989, Winchester, UK Salisbury Med Bull Special suppl No. 68 pp 49\u201352","journal-title":"UK Salisbury Med Bull Special suppl"},{"key":"3_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0882-4010(88)90015-0","volume":"5","author":"SL Welkos","year":"1988","unstructured":"Welkos SL, Friedlander AM (1988) Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microbiol Pathog 5: 127\u2013139","journal-title":"Microbiol Pathog"},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1006\/mpat.1993.1037","volume":"14","author":"SL Welkos","year":"1993","unstructured":"Welkos SL, Vietri NJ, Gibbs PH (1993) Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence. Microbial Pathogenesis 14: 381\u2013388","journal-title":"Microbial Pathogenesis"},{"key":"3_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1365-2672.1999.00901.x","volume":"87","author":"ED Williamson","year":"1999","unstructured":"Williamson ED, Beedham RJ, Bennett AM, Perkins SD, Miller J, Baillie LW J (1999) Presentation of protective antigen to the mouse immune system: immune sequelae. J Appl Microbiol 87: 315\u2013317","journal-title":"J Appl Microbiol"},{"key":"3_CR98","unstructured":"Wilson GS, Miles AA (1955) Anthrax. In: Topley and Wilson\u2019s Principles of Bacteriology and Immunity. Williams Wilkins, Baltimore, pp 1938\u20131954"},{"key":"3_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/w98-108","volume":"45","author":"PL Worsham","year":"1999","unstructured":"Worsham PL, Sowers MR (1999) Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis. Can J Microbiol 45: 1\u20138","journal-title":"Can J Microbiol"},{"key":"3_CR100","doi-asserted-by":"crossref","unstructured":"Wright GG, Green T, Kanode Jr R (1954) Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen. J Immunol 73:387\u2013 391","DOI":"10.4049\/jimmunol.73.6.387"},{"key":"3_CR101","first-page":"87","volume-title":"Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei","author":"ND Zegers","year":"1998","unstructured":"Zegers ND, Kluter E, van der Stap H, van Dura E, van Dalen P, Shaw M, Baillie L (1998) Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: Towards the development of an oral vaccine against anthrax. J Appl Microbiol 87: 309\u2013314"}],"container-title":["Current Topics in Microbiology and Immunology","Anthrax"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-662-05767-4_3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T17:39:57Z","timestamp":1714844397000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-662-05767-4_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783642077999","9783662057674"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-3-662-05767-4_3","relation":{},"ISSN":["0070-217X"],"issn-type":[{"value":"0070-217X","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}